Last updated 2026-07-26
- Raised $30M Series D led by CTech, Mar 2025
- Raised $6M Series C led by Almeda Ventures, Nov 2020
- Raised $5M Seed round led by NGT3VC, Apr 2014
Total raised
$51.2M
Last: Undisclosed Round 2025-03
Stage
Series B
Founded
2014
Headcount
28
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences
About
Nurami Medical is a biotechnology-driven company dedicated to modernizing soft tissue surgical repair through innovative nanofiber and biomaterial technologies. The company develops bio surgical implants that promote healing and address complications associated with current soft tissue implants, such as dangerous leaks, and promote healthy tissue formation. Their proprietary, electrospun-based platform technology enables the creation of an innovative category of bio surgical implants to seal and heal wounds effectively. Nurami's products are designed to improve surgical outcomes and patient lives, particularly in neurosurgery for dura repair.
Funding history · 11 rounds · $51.2M total
2025-11
Grant
Undisclosed
★ European Innovation Council (EIC) program
2025-03
D Round
$30.0M
★ CTech★ Iron Nation★ NGT HealthCare II★ MedTech Innovator★ additional investorsOppenheimer & Co. Inc.
2024-07
Grant
$2.7M
★ Iron Nation★ EIC Accelerator
2024-07
Grant
$4.0M
★ Israel Innovation Authority
2023-01
Grant
Undisclosed
★ European Innovation Council★ Israel Innovation Authority
2020-11
C Round
$6.0M
★ Almeda VenturesGlenrockAmir BlattTzachi SultanRatio Technologiesadditional investorsNGT3VC venture capital fundIsrael Innovation Authority
2018-11
Grant
$375K
2018-06
B Round
$2.0M
★ Zhongguancun Translational Medicine Science & Technology★ Beijing Jishi Daze Biological Science & Technology Center
2017-11
Grant
$490K
2016-12
A Round
$675K
★ NGT3★ NGT3VC★ Alfred Mann Foundation★ Office of the Chief Scientist★ AMIT-Technion ( The Alfred Mann Institute)NGT3 incubator (NGT3VC)Israel's Office of the Chief ScientistAMIT-Technion (The Alfred Mann Institute)
2014-04
Seed
$5.0M
★ NGT3VC★ Israel Innovation Authority★ Office of the Chief Scientist (Israel)Dr. Amir BaharNGT3VC IncubatorNora Nseir Manassa
Headcount over time
From 4 (2018-09) to 34 (2026-01) · +30 (+750%) · 29 points · source: Finder history + radar grounding
Q&A
- What is Nurami Medical's primary focus?
- Nurami Medical is a biotechnology company focused on advancing innovation in soft-tissue repair using nanofibers and engineered biomaterials to improve patient recovery.
- When was Nurami Medical founded?
- Nurami Medical was founded in 2014.
- How many employees does Nurami Medical currently have?
- Nurami Medical has 11-50 employees.
- What was Nurami Medical's most recent funding round?
- In March 2025, Nurami Medical secured a C Round of $30,000,000. The round included investors such as Israel Innovation Authority.
- Has Nurami Medical received any grants recently?
- Yes, in July 2024, Nurami Medical received a grant of $2,695,274 from the Israel Innovation Authority (IIA) and the European Innovation Council (EIC) Accelerator program.
- Which product of Nurami Medical received FDA clearance?
- Nurami Medical's ArtiFascia® Dura Substitute received FDA clearance in August 2023.
- What was the amount and lead investors of Nurami Medical's B Round?
- In November 2020, Nurami Medical raised $6,000,000 in a B Round led by.
- What is ArtiFascia?
- ArtiFascia is Nurami Medical's first soft-tissue repair product, a multilayer, Dural repair graft made of biocompatible and bioabsorbable polymers with an integrated barrier layer and a biomimetic structure of electrospun fibers designed to promote neodura regeneration. It is available for commercial use in the USA and has FDA 510(k) clearance.
Team · 2
Nora Nseir Manassa
Founder · Founder and CEO
Amir Bahar
Founder · Founder and COO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesNanomaterialsPolymersImplants
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesBiotechnology
Business model
B2B
Highlights
1 PatentsVerified
Tags
surgeonsbiodegradablenanotechnologysurgeryneurologydoctorshospitalsmedical-technologiesregenerative-medicinefibersneurosurgerylife-sciencesmedical-devicesbiotechnologybiomaterialstissue-regeneration
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | nurami-medical.com |
|---|---|
| linkedin.com/company/5222266 | |
| facebook.com/Nurami-Medical-111635057259570 |
Identifiers & details
| Legal name | Nurami Medical Ltd. |
|---|---|
| Founded | 2014 |
| Employees (exact) | 28 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | nurami-medical.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515038594 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2014-04-01 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 11 — other (1), people (2), shares_capital (2), annual_report (1), charge (5) |
| Registered address | חת נחום 7 טירת כרמל |
Recent registry events
| Date | Event |
|---|---|
| 2026-07-23 | עדכון כתובת ו/או מען דיגיטלי |
| 2026-07-22 | עדכון דירקטורים-הסרת דירקטור |
| 2026-07-22 | הקצאת מניות |
| 2026-07-22 | עדכון דירקטורים-הוספת דירקטור |
| 2025-10-20 | דו~ח שנתי |
| 2026-04-20 | סילוק שעבוד |
| 2026-04-20 | רישום שעבוד |
| 2026-04-20 | רישום שעבוד |
| 2026-01-19 | העברת מניות |
| 2026-05-17 | סילוק שעבוד |
| 2026-04-16 | סילוק שעבוד |